US Bancorp’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
3C
US Bancorp's ASTH Position: Q2 2026 in Review
US Bancorp reduced its Astrana Health (ASTH) stake by 2.6% in Q2 2026, selling an estimated $288 and leaving 296 shares worth $13.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3353.
US Bancorp first reported a position in ASTH in Q1 2021 and has held it in 19 quarters since. The position peaked at $8.4M in Q3 2021. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.
- US Bancorp held 296 shares of Astrana Health worth $13.7K as of Q2 2026.
- US Bancorp sold 8 Astrana Health shares in Q2 2026, an estimated $288.
- Astrana Health made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3353 holding.
- US Bancorp first reported a position in Astrana Health in Q1 2021 and has held it in 19 quarters since.
- US Bancorp's Astrana Health position peaked at $8.4M in Q3 2021.
- 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.